Actively Recruiting
Comparing Knee Injections of Hyaluronic Acid With and Without Platelet-Rich Plasma for Osteoarthritis Treatment
Led by Implai Sp z o.o · Updated on 2026-08-25
50
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the clinical performance and safety of a single knee injection combining hyaluronic acid HA with autologous platelet-rich plasma PRP compared to HA alone in adults with symptomatic knee osteoarthritis classified as Kellgren-Lawrence grade II or III. Knee osteoarthritis is a chronic joint disease causing pain and reduced quality of life. This study is a prospective, randomized, open-label, single-center post-market clinical follow-up investigation. Participants will be randomized to receive either one intra-articular injection of 3.8 mL HA combined with 1 mL autologous PRP prepared from their own blood or a single injection of 4.8 mL HA alone. Both medical devices are CE-marked and used as intended. After injection, participants will be followed for 18 months to assess outcomes. Throughout the study, participants will have their knee pain intensity measured using the Numeric Rating Scale NRS at baseline and multiple time points up to 18 months. Additional assessments include the Western Ontario and McMaster Universities Osteoarthritis Index WOMAC, Knee Injury and Osteoarthritis Outcome Score KOOS, quality of life measures, and safety monitoring for adverse events. The primary outcome is the difference in knee pain change between groups at 6 months.
CONDITIONS
Brief Title
Efficacy of Platelet-Rich Plasma Added to Hyaluronic Acid in Knee Osteoarthritis
Research Team
E
Eliza Fiedorczuk
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here